Jazz Pharmaceuticals Plc Stock Analysis
| JAZZ Stock | USD 125.05 0.42 0.34% |
Jazz Pharmaceuticals PLC is undervalued with Real Value of 140.45 and Hype Value of 121.58. The main objective of Jazz Pharmaceuticals stock analysis is to determine its intrinsic value, which is an estimate of what Jazz Pharmaceuticals PLC is worth, separate from its market price. There are two main types of Jazz Pharmaceuticals' stock analysis: fundamental analysis and technical analysis.
The Jazz Pharmaceuticals stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Jazz Pharmaceuticals is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day. Jazz Stock trading window is adjusted to America/New York timezone.
Jazz |
Jazz Stock Analysis Notes
About 98.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.8. Some equities with similar Price to Book (P/B) outperform the market in the long run. Jazz Pharmaceuticals PLC has Price/Earnings To Growth (PEG) ratio of 0.85. The entity recorded earning per share (EPS) of 7.06. The firm had not issued any dividends in recent years. Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. Jazz Pharmaceuticals plc was incorporated in 2003 and is headquartered in Dublin, Ireland. Jazz Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 3200 people. To learn more about Jazz Pharmaceuticals PLC call Bruce Cozadd at 353 1 634 7800 or check out https://www.jazzpharma.com.Jazz Pharmaceuticals PLC Investment Alerts
| Jazz Pharmaceuticals has a strong financial position based on the latest SEC filings | |
| Over 98.0% of the company shares are owned by institutional investors |
Jazz Pharmaceuticals PLC Upcoming and Recent Events
Earnings reports are used by Jazz Pharmaceuticals to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
| 6th of March 2024 Upcoming Quarterly Report | View | |
| 8th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 6th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Jazz Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 7.37 B.Jazz Profitablity
The company has Profit Margin (PM) of 0.12 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.25 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.25.Technical Drivers
As of the 5th of February, Jazz Pharmaceuticals retains the Market Risk Adjusted Performance of 0.2524, downside deviation of 1.37, and Risk Adjusted Performance of 0.0305. Jazz Pharmaceuticals technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.Jazz Pharmaceuticals PLC Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Jazz Pharmaceuticals middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Jazz Pharmaceuticals PLC. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Jazz Pharmaceuticals PLC Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Jazz Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Jazz Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Jazz Pharmaceuticals insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Bruce Cozadd over a month ago Disposition of 1500 shares by Bruce Cozadd of Jazz Pharmaceuticals at 123.43 subject to Rule 16b-3 | ||
Bruce Cozadd over three months ago Disposition of 1000 shares by Bruce Cozadd of Jazz Pharmaceuticals at 110.84 subject to Rule 16b-3 | ||
Patricia Carr over six months ago Disposition of 163 shares by Patricia Carr of Jazz Pharmaceuticals at 108.825 subject to Rule 16b-3 | ||
Kennedy Patrick over six months ago Insider Trading | ||
Rick Winningham over a year ago Acquisition by Rick Winningham of 3075 shares of Jazz Pharmaceuticals subject to Rule 16b-3 | ||
Matthew Young over a year ago Payment of 1348 shares by Matthew Young of Jazz Pharmaceuticals subject to Rule 16b-3 |
Jazz Pharmaceuticals Outstanding Bonds
Jazz Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Jazz Pharmaceuticals PLC uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Jazz bonds can be classified according to their maturity, which is the date when Jazz Pharmaceuticals PLC has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View |
Jazz Pharmaceuticals Predictive Daily Indicators
Jazz Pharmaceuticals intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Jazz Pharmaceuticals stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Jazz Pharmaceuticals Forecast Models
Jazz Pharmaceuticals' time-series forecasting models are one of many Jazz Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Jazz Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Jazz Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Jazz Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Jazz shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Jazz Pharmaceuticals. By using and applying Jazz Stock analysis, traders can create a robust methodology for identifying Jazz entry and exit points for their positions.
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. Jazz Pharmaceuticals plc was incorporated in 2003 and is headquartered in Dublin, Ireland. Jazz Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 3200 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Jazz Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Global Markets Map Now
Global Markets MapGet a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
| All Next | Launch Module |
Additional Tools for Jazz Stock Analysis
When running Jazz Pharmaceuticals' price analysis, check to measure Jazz Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jazz Pharmaceuticals is operating at the current time. Most of Jazz Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Jazz Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jazz Pharmaceuticals' price. Additionally, you may evaluate how the addition of Jazz Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.